Ethical Funding for Expanded Research and Treatment Options
Historically, the MPN Research Foundation has relied on donations from MPN patients, families and friends to fund research grants. But with NIH and other sources reducing funding for medical research, it has become increasingly difficult to fund scientists on the leading edge of MPN research.
After careful deliberation and consultation with other foundations about best practices, we have elected to accept funding from the biotech and pharmaceutical industry to augment the funds we have available for research. However, we remain committed to product and company neutrality, as defined to the MPN Research Foundation Neutrality Policy below.
As we race to utilize every available tool in the fight to change the prognosis for MPN patients, it’s our hope that our relationships with companies in the biotech and pharmaceutical industry will enable us to further expand the research that is driving the development of new and effective treatments.
The MPN Research Foundation Neutrality Policy
The MPN Research Foundation welcomes and accepts monetary and in-kind donations to support medical research from companies in the biotech, pharmaceutical and related industries.
The MPN Research Foundation provides no goods, services or rights in return for these donations and makes no commitment or effort to promote or endorse specific companies or products. Industry contributions in no way influence our grant-making decisions.
To ensure transparency, the Foundation publishes a list of all corporate donors on our website.
The MPN Research Foundation may also accept grants and in-kind donations to support patient and health care professional education programs and educational materials. All content for sponsored education programs and materials is subject to approval by MPN Research Foundation Scientific Advisory Board (SAB) and/or other independent reviewers. Donors to education programs and materials will be acknowledged in the appropriate venues.